FDA Approves Chair Sensor for Patient Monitoring
The U.S. Food and Drug Administration has granted market approval to EarlySense of Waltham, Mass., for its chair sensor solution.
The U.S. Food and Drug Administration has granted market approval to EarlySense of Waltham, Mass., for its chair sensor solution.
The chair sensor, which continuously monitors patients heart rate, respiratory rate and movement, was recently evaluated at Coffee Regional Medical Center in Douglas, Ga., where it successfully enabled the clinical team to proactively respond to early signs of patient deterioration and to prevent patient falls. EarlySense says this is the first contact-free sensor for vital sign monitoring in a chair.
"Clinicians have long known that ambulating patients from bed to chair improves healing, reduces the risk of complications, and shortens length of stay," said the company in a statement. "Moving around in an upright position appears to be of most benefit in the early post-operative period and to improve lung function and reduce potential pulmonary complications. But to date there was not automatic contact-free solution for keeping patients safe in their chairs."
The chair sensor, which continuously monitors patients heart rate, respiratory rate and movement, was recently evaluated at Coffee Regional Medical Center in Douglas, Ga., where it successfully enabled the clinical team to proactively respond to early signs of patient deterioration and to prevent patient falls. EarlySense says this is the first contact-free sensor for vital sign monitoring in a chair.
"Clinicians have long known that ambulating patients from bed to chair improves healing, reduces the risk of complications, and shortens length of stay," said the company in a statement. "Moving around in an upright position appears to be of most benefit in the early post-operative period and to improve lung function and reduce potential pulmonary complications. But to date there was not automatic contact-free solution for keeping patients safe in their chairs."